Pet Drug Reports

Sulfadiazine + Trimethoprim (Tribrissen, Di-Trim): adverse event reports that FDA received

Combination of 2 active ingredients

Also sold as: Tribrissen, Di-Trim, EQUISUL-SDT, Uniprim, Tucoprim.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

From March 1987 to March 2026, FDA received 286 adverse event reports that name a drug with sulfadiazine and trimethoprim as its active ingredients. Of the 286 reports, 95 (33.2%) are about dogs. 95 reports are about horses (33.2%).

In January to March 2026, FDA received 1 report that names this drug. The signs that appear in the largest number of the 286 reports are "Death", "Diarrhoea" and "Depression". A report is not proof that a drug caused a sign.

Fewer than 20 reports named this drug in the 12 months before June 2026, so this page gives no change. Reports about dogs are 33.2% of the reports that name this drug, and 72.6% of all reports.

Search engines list a drug page with 500 reports or more in all years. The page also needs 30 reports or more in the 12 months to June 2026. This page is under one of these numbers. The site keeps the page and keeps it out of search engines.

Since the last update of the FDA data

The latest update of the FDA data, recorded on , changed no count of this page.

January to March 2026 is the latest closed quarter in the data. In that quarter FDA received 1 report that names sulfadiazine + trimethoprim: 1 dog, 0 cat, 0 horse, 0 other or not given.

All updatesFeed of updates (RSS)

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 286 reports that list the sign. One report can list more than one sign.

The sign that is in the largest number of the reports comes first.

  1. Death18.5%53 reports
  2. Diarrhoea[diarrhea]9.8%28 reports
  3. Depression[dull, quiet or withdrawn]9.1%26 reports
  4. Anorexia[not eating]8.7%25 reports
  5. Collapse8.4%24 reports
  6. Vomiting6.6%19 reports
  7. Fever5.9%17 reports
  8. Anaemia NOS[low red blood cell count]5.2%15 reports
  9. Anaphylaxis[sudden severe allergic-type reaction]5.2%15 reports
  10. Convulsion[seizure]5.2%15 reports
  11. Thrombocytopenia[low platelet count]5.2%15 reports
  12. Death by euthanasia[the animal was euthanized]4.9%14 reports
  13. Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]4.9%14 reports
  14. Accidental exposure[exposure that was not intended]3.1%9 reports
Show the next 16 signs
  1. Containers, Abnormal[a product quality report, not a sign in an animal]3.1%9 reports
  2. Pruritus[itching]3.1%9 reports
  3. Seal, Abnormal[a product quality report, not a sign in an animal]3.1%9 reports
  4. Abdominal pain2.8%8 reports
  5. Epistaxis[nosebleed]2.8%8 reports
  6. Lethargy[unusually tired or inactive]2.8%8 reports
  7. Leucocytosis NOS[high white blood cell count]2.8%8 reports
  8. Color, Abnormal[a product quality report, not a sign in an animal]2.4%7 reports
  9. Dyspnoea[difficulty breathing]2.4%7 reports
  10. Elevated blood urea nitrogen (BUN)[a kidney value above the normal range]2.4%7 reports
  11. Elevated serum alkaline phosphatase (SAP)[a liver and bone enzyme above the normal range]2.4%7 reports
  12. Injection site swelling[swelling where the injection was given]2.4%7 reports
  13. Joint swelling2.4%7 reports
  14. Lameness2.4%7 reports
  15. Other abnormal test result NOS[abnormal laboratory result, type not specified]2.4%7 reports
  16. Agitation2.1%6 reports

The list shows 30 of 335 coded signs. A report is not proof that a drug caused a sign. Download all signs (CSV)

Reports by species

The share is of all 286 reports that name sulfadiazine + trimethoprim. The other reports give a different species or no species.

Reports for each month, Jul 2021 to Jun 2026

Dog4 reports

No chart: no month has 5 or more reports.

Cat1 report

No chart: no month has 5 or more reports.

Horse9 reports

No chart: no month has 5 or more reports.

Other or not given6 reports

No chart: no month has 5 or more reports.

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name sulfadiazine + trimethoprim, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
202610001
202500415
202420024
202310315
202201214
202100022
202021014
201911024
201800336
201701045
201610337
201520226
201410258
201341038
201210113
201110214
201000314
2009003710
200800145
200700066
2006106411
200520103
200400426
2003212510
200230115
2001505414
20004111824
1999542112
199820204
199750139
199630014
1995810110
199450016
199340004
199270108
199116015031
1990505212
198900202
198801506
198710304

2026 has the reports that FDA received through Mar 2026. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal4.2%12
  • Recovered with Sequela[recovered, with a lasting effect]1%3
  • Ongoing4.5%13
  • Died22.4%64
  • Euthanized1.7%5
  • Outcome Unknown2.4%7

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 286 reports that name sulfadiazine + trimethoprim.

A report about more than one animal can have more than one outcome.

Kind of report

  • Safety issue75.9%217
  • Lack of expected effectiveness1%3
  • Both safety and lack of expected effectiveness0.7%2
  • Manufacturing or product defect22.4%64
  • Other0%0

40 reports say if the event was serious. 55% of them have the serious flag. The person who sends the report sets the flag.

Show age, weight, breed and route

Age of the animal

  • Under 1 year7.3%21
  • 1 to 3 years18.5%53
  • 4 to 7 years14.7%42
  • 8 to 11 years12.2%35
  • 12 years and over12.2%35
  • Age not given35%100

Weight of the animal

  • Under 5 kg (11 lb)5.6%16
  • 5 to 9.9 kg (11 to 22 lb)7%20
  • 10 to 24.9 kg (22 to 55 lb)5.6%16
  • 25 to 44.9 kg (55 to 99 lb)11.2%32
  • 45 kg and over (99 lb and over)26.9%77
  • Weight not given43.7%125

Breed, where the report gives one breed

A breed with many animals has many reports.

Route in the report

  • Oral54.2%155
  • Intravenous14%40
  • Subcutaneous1.7%5
  • Intramuscular1.4%4

Each bar is on a scale of 0 to 100%.

Approved animal drugs with these active ingredients (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Brand names

  • Tribrissen
  • Di-Trim
  • EQUISUL-SDT
  • Uniprim
  • Tucoprim

What the Green Book records give

Applications with an approval in force
11
Approved species
Dogs, Equids, Horses
Dose forms
Tablet, Liquid, Paste, Liquid (Solution), Liquid (Suspension), Oral Suspension, Powder
Routes
Oral, Intravenous, Subcutaneous
Sale
RX (prescription)
Earliest approval date in the records

The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.

Applications in the Green Book of 2 Nov 2026, pioneer applications (NADA) first
Brand nameActive ingredientsSponsorApproved speciesApplication
Tribrissen 120 Tablets; Tribrissen 30 Tablets; Tribrissen 480 Tablets; Tribrissen 960 TabletsSulfadiazine, TrimethoprimIntervet, Inc.DogsNADA 095-614
Tribrissen 48% InjectionSulfadiazine, TrimethoprimIntervet, Inc.HorsesNADA 106-965
Di-Trim TabletsSulfadiazine, TrimethoprimZoetis Inc.DogsNADA 115-578
Tribrissen 400 Oral PasteSulfadiazine, TrimethoprimIntervet, Inc.HorsesNADA 131-918
Di-Trim 24%Sulfadiazine, TrimethoprimZoetis Inc.DogsNADA 132-486
Di-Trim 48% InjectionSulfadiazine, TrimethoprimZoetis Inc.HorsesNADA 134-778
Di-Trim 400 PasteSulfadiazine, TrimethoprimZoetis Inc.HorsesNADA 136-342
Tribrissen 60 Oral SuspensionSulfadiazine, TrimethoprimIntervet, Inc.DogsNADA 136-741
EQUISUL-SDTSulfadiazine, TrimethoprimAurora Pharmaceutical, Inc.HorsesNADA 141-360
Uniprim PowderSulfadiazine, TrimethoprimNeogen Corp.HorsesANADA 200-033
Tucoprim PowderSulfadiazine, TrimethoprimZoetis Inc.HorsesANADA 200-244

Other pages with one of these ingredients

A report names a drug by its set of active ingredients. Each set has its own page. The list is in order of name.

Next in the A to Z list

All drugs by active ingredient. Brand names A to Z

FDA pages for this drug

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Sulfadiazine + Trimethoprim: adverse event reports that FDA received. https://petdrugreports.com/drug/sulfadiazine-trimethoprim/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. The site does not use the application number that a record has.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists the brand names with these active ingredients.

Do the reports show that the drug caused the signs?

No. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 6 reports in the 12 months to June 2026. It received 2 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 286 reports received from March 1987 to March 2026, 75.9% are about a safety issue only. 1.7% are about a lack of expected effectiveness, alone or with a safety issue. 22.4% are about a defect of the product or its package.